Self-Care 2025: PPCP, Regulatory, Cultural Aspects

0.0(0)
studied byStudied by 0 people
learnLearn
examPractice Test
spaced repetitionSpaced Repetition
heart puzzleMatch
flashcardsFlashcards
Card Sorting

1/50

encourage image

There's no tags or description

Looks like no tags are added yet.

Study Analytics
Name
Mastery
Learn
Test
Matching
Spaced

No study sessions yet.

51 Terms

1
New cards

5 core components of PPCP

collect, assess, plan, implement, follow up

2
New cards

collect

Collection of the necessary subjective and objective information about the patient in order to understand the relevant medical/medication history and clinical status of the patient

3
New cards

assess

Assess the information collected and analyze the clinical effects of the patient's therapy in the context of the patient's overall health goals in order to identify and prioritize problems and achieve optimal care

4
New cards

plan

Develop an individualized patient-centered care plan in collaboration with other health care professionals and the patient or caregiver that is evidence-based and cost-effective

5
New cards

implement

Implement the care plan in collaboration with other health care professionals and the patient of caregiver

6
New cards

follow up

Monitor and evaluate the effectiveness of the care plan and modify the plan in collaboration with other health care professionals and the patient or caregiver as needed

7
New cards

why pharmacists are responsible for knowing exclusions for self-treatment

The patient may need additional drug therapy that requires a prescription and assessment from another health care provider. A medication solution may not be applicable and the patient may need a therapy alternative. To ensure the best health outcomes it is important to know when to refer a patient to seek other help.

8
New cards

QuEST

quickly, establish, suggest, talk

9
New cards

Qu

Quickly and accurately assess the patient

10
New cards

E

Establish that the patient is an appropriate self-care candidate

- no severe symptoms

- no symptoms that persist or return repeatedly

11
New cards

S

Suggest appropriate self-care strategies

12
New cards

T

Talk with the patient

13
New cards

SCHOLAR-MACS

- symptoms

- characteristics

- history

- onset

- location

- aggravating factors

- remitting factors

- medications

- allergies

- conditions

- social history

14
New cards

symptoms

What are the main and associated symptoms?

15
New cards

characteristics

What is the situation like? Is it changing?

16
New cards

history

What has been done so far? Has this happened before, and, if so, what was done then? What was successful? What wasn't?

17
New cards

onset

When did it start?

18
New cards

location

Where is the problem?

19
New cards

aggravating factors

What makes it worse?

20
New cards

remitting factors

What makes it better?

21
New cards

medications

Prescription and nonprescription as well as complementary and alternative products

22
New cards

allergies

To medications and other substances

23
New cards

conditions

Coexisting health conditions

24
New cards

social history

Ask about alcohol, tobacco, diet, occupation, etc.

25
New cards

SCHOLAR-MAC PPCP step

collect

26
New cards

establish PPCP step

assess

27
New cards

suggest PPCP step

plan

28
New cards

talk PPCP step

implementation

29
New cards

prescription vs. non-prescription standards of safety and efficacy

they are regulated differently but both are held to the same standards of safety and efficacy

30
New cards

Pure Food and Drug Act of 1906

Prohibits adulteration and misbranding

31
New cards

Food, Drug and Cosmetic Act (1938)

Mandated safety of foods, drugs and cosmetics

32
New cards

Durharm-Humphrey Amendment (1951)

Provided statutory basis for two classes of drugs prescription and nonprescription

33
New cards

Kefauver-Harris Drug Amendments (1962)

Required proven efficacy for marketed products including nonprescription drugs

34
New cards

FDA mandated components of a "Drug Facts" label

active ingredients

purpose

uses

warnings

directions

inactive ingredients

35
New cards

Dietary Supplement Health and Education Act (DSHEA) (1994)

Defines dietary supplements as vitamins, minerals, herb or other botanical, amino acid, a substance which increases the dietary intake of it or a concentrate, metabolite, constituent, extract, or combination of any ingredient described above

36
New cards

The Food and Drug Modernization Act (1997)

Established inactive ingredient labeling requirements

37
New cards

Dietary Supplement and Nonprescription Drug Consumer Protection Act (2006)

Mandated reporting of serious adverse drug reactions by dietary supplement and nonprescription drug manufacturers

38
New cards

Pseudoephedrine limit per person within 24 hours

3.6g

39
New cards

pseudoephedrine limit per person within 30 days

7.5g

40
New cards

pseudoephedrine schedule class

class V

41
New cards

how long pseudoephedrine log should be kept

24 months

42
New cards

minimum age to purchase pseudoephedrine

18

43
New cards

pseudoephedrine maintained ____ the counter

behind

44
New cards

patient must sign and present ID with purchase of pseudoephedrine

true

45
New cards

OTC labeling components

- active ingredient

- purpose

- uses

- warnings

- directions

- other information

- inactive ingredients

46
New cards

nonprescription medication regulation

Regulated by CDER (Center For Drug Evaluation and Research) of FDA

47
New cards

nutritional/dietary supplements regulation

Regulated as foods not drugs

48
New cards

natural products and homeopathic remedies regulation

•Regulated by HPCUS (Homeopathic Pharmacopoeia of the US)

•Must have a self-limiting, self-diagnosable condition

49
New cards

key considerations for Rx switch to OTC

•Can the patient adequately self-diagnose the clinical abnormality?

•Can the clinically abnormal condition be successfully self-treated?

•Is the self-treatment product safe and effective for consumer use under conditions of actual use?

50
New cards

behind the counter medications

•Rx not required but product kept behind pharmacy counter and requires pharmacist to dispense.

•Benefit to consumer: Greater access to meds that require safeguards to use.

•Current examples:

•Sudafed (Pseudoephedrine-PSE)

Plan B One Step (Levonorgestrel)

51
New cards

liability nonprescription products

•Products liability refers to the liability of any or all parties along the chain of manufacture of any product for damage caused by that product. This includes the manufacturer of component parts (at the top of the chain), an assembling manufacturer, the wholesaler, and the retail store owner (at the bottom of the chain).